TheEdgeResearch
Home / Stocks / STSS

SkyAI, Inc. (STSS)

NASDAQ Healthcare Medical - Instruments & Supplies
$1.27 ▼ -2.31%
Market Cap
$53.7M
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Beta
2.10
52-Wk Range
0.9431-18.23
CEO
Paul K. Danner
Country
US
Currency
USD

SkyAI, Inc. operates in the Medical - Instruments & Supplies industry of the Healthcare sector, headquartered in Melville, NY, US. The stock last traded at $1.27, down 2.31% on the session, giving a market capitalisation of $53.7M. On trailing twelve-month figures it carries a trailing P/E of -0.10, a net margin of -15914.9%. Its beta of 2.10 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-0.10
Price / Sales
21.52
Price / Book
0.58
EV / EBITDA
-0.11
Gross margin
13.0%
Operating margin
-1450.1%
Net margin
-15914.9%
Return on equity
Debt / equity
0.00
Current ratio
5.35
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ
Employees
55
IPO date
2022-04-14
Headquarters
Melville, NY, US
About SkyAI, Inc.

Sharps Technology, Inc., a medical device and pharmaceutical packaging company, provides smart-safety syringe products to the healthcare industry. Its product lines focus on providing waste capabilities that incorporate syringe technologies. The company, through a digital asset treasury strategy, focuses on accumulating Solana (SOL), the native digital asset of the Solana blockchain. The company was incorporated in 2017 and is based in Melville, New York.

Comparable companies

SkyAI, Inc. is most often compared with the following Healthcare names:

ACONAGPUGCTKGMVDFHSCSHTCRNXGLPDEXSMFLSPRC
More research on STSS
STSS technical analysis STSS TheEdge Score Compare against peers
Open full interactive analysis & DCF →